microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges - Université Grenoble Alpes Accéder directement au contenu
Article Dans Une Revue Frontiers in Endocrinology Année : 2016

microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges


Adrenocortical carcinoma (ACC) is a rare malignancy with poor prognosis and limited therapeutic options. Over the last decade, pan-genomic analyses of genetic and epigenetic alterations and genome-wide expression profile studies allowed major advances in the understanding of the molecular genetics of ACC. Besides the well-known dysfunctional molecular pathways in adrenocortical tumors, such as the IGF2 pathway, the Wnt pathway, and TP53, high-throughput technologies enabled a more comprehensive genomic characterization of adrenocortical cancer. Integration of expression profile data with exome sequencing, SNP array analysis, methylation, and microRNA (miRNA) profiling led to the identification of subgroups of malignant tumors with distinct molecular alterations and clinical outcomes. miRNAs post-transcriptionally silence their target gene expression either by degrading mRNA or by inhibiting translation. Although our knowledge of the contribution of deregulated miRNAs to the pathogenesis of ACC is still in its infancy, recent studies support their relevance in gene expression alterations in these tumors. Some miRNAs have been shown to carry potential diagnostic and prognostic values, while others may be good candidates for therapeutic interventions. With the emergence of disease-specific blood-borne miRNAs signatures, analyses of small cohorts of patients with ACC suggest that circulating miRNAs represent promising non-invasive biomarkers of malignancy or recurrence. However, some technical challenges still remain, and most of the miRNAs reported in the literature have not yet been validated in sufficiently powered and longitudinal studies. In this review, we discuss the current knowledge regarding the deregulation of tumor-associated and circulating miRNAs in ACC patients, while emphasizing their potential significance in pathogenic pathways in light of recent insights into the role of miRNAs in shaping the tumor microenvironment.

Dates et versions

hal-02459146 , version 1 (29-01-2020)



Nadia Cherradi. microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges. Frontiers in Endocrinology, 2016, 6, pp.195. ⟨10.3389/fendo.2015.00195⟩. ⟨hal-02459146⟩


16 Consultations
0 Téléchargements



Gmail Mastodon Facebook X LinkedIn More